Select Page

Omicron Variant Prolongs Temporary Pause on FDA Inspections

Read about how the latest COVID variant, Omicron, has lead the FDA to put a temporary pause on surveillance inspections and how this impacts the production of FDA-regulated products for US consumption.

Get The Newsletter

⇒ Analysis of the latest life science news 

⇒ Coverage of pharma, healthcare and biotech

⇒ Interviews and insights with industry insiders

Follow Us